C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2002
11/26/2002	US6486113 Mutant α-amylases
11/26/2002	US6485977 Recombinant constructs and techniques for delivering to eucaryotic cells bacterial proteins that are secreted via type III secretion systems
11/26/2002	US6485976 Use of adeno-associated virus (AAV) to deliver genes
11/26/2002	US6485974 Antisense modulation of PTPN2 expression
11/26/2002	US6485973 Oligonucleotides specific for the marORAB operon
11/26/2002	US6485968 Ectoparasite saliva proteins and apparatus to collect such proteins
11/26/2002	US6485967 Human neuronal nicotinic acetylcholine receptor α6 and β3 nucleic acid
11/26/2002	US6485966 Hybrid microorganism for use in gene therapy
11/26/2002	US6485965 Replicating or semi-replicating viral constructs, preparation and uses for gene delivery
11/26/2002	US6485964 Transgenic mammals lacking expression of erythropoietin or of erythropoietin receptor, transgenic mammals expressing chimeric erythropoietin receptors, constructs for producing the transgenic mammals and uses therefor
11/26/2002	US6485960 Polycystic kidney disease 1 gene and uses thereof
11/26/2002	US6485958 Method for producing recombinant adenovirus
11/26/2002	US6485957 DNA encoding the human serine protease EOS
11/26/2002	US6485954 Enzyme with galactanase activity
11/26/2002	US6485951 Derived from pseudomonas jessenii
11/26/2002	US6485948 Carbonyl reductase, method for producing said enzyme, DNA encoding said enzyme, and method for producing alcohol using said enzyme
11/26/2002	US6485947 Production of lactate using crabtree negative organisms in varying culture conditions
11/26/2002	US6485944 Replica amplification of nucleic acid arrays
11/26/2002	US6485942 Variants of vascular endothelial cell growth factor having altered pharmacological properties, and recombinant methods of production
11/26/2002	US6485940 Broad spectrum infectious bursal disease virus vaccine
11/26/2002	US6485937 System for rapid generation of recombinant baculovirus-based expression vectors for silkworm larvae
11/26/2002	US6485936 Heat shock transcription factor-binding protein
11/26/2002	US6485935 Structure of the ankyrin binding domain of a α-Na, K-ATPase
11/26/2002	US6485934 Regulatory system for inducible expression of genes with lambdoid promoters
11/26/2002	US6485933 B cell receptor associated proteins
11/26/2002	US6485930 Mannosyl transfer with regeneration of GDP-mannose
11/26/2002	US6485920 Growth factor antagonist materials and methods
11/26/2002	US6485919 Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof
11/26/2002	US6485917 Method for synthesizing cDNA
11/26/2002	US6485915 Analytical element for species-specific detection of nucleic acids
11/26/2002	US6485914 Method of detecting chlamydia pneumoniae gene using polynucleotides
11/26/2002	US6485912 Methods of performing gene trapping in bacterial and bacteriophage-derived artificial chromosomes and use thereof
11/26/2002	US6485911 Methods for determining risk of developing alzheimer's disease by detecting mutations in the presenilin 2 (PS-2) gene
11/26/2002	US6485909 DNA polymerase having ability to reduce innate selective discrimination against fluorescent dye-labeled dideoxynucleotides
11/26/2002	US6485908 Mutation within the connexin 26 gene responsible for prelingual non-syndromic deafness and method of detection
11/26/2002	US6485907 PCR-based detection of Rhizoctonia cerealis
11/26/2002	US6485906 Detecting preferential nucleotide sequences in sample; obtain nucleotide sequences, incubate with primers, detect signal determining the degree of hybridization
11/26/2002	US6485904 DNA encoding a plasminogen activating protein
11/26/2002	US6485903 Methods and reagents for combined PCR amplification and hybridization probing
11/26/2002	US6485900 Synthetic antigen for the detection of AIDS-related disease
11/26/2002	US6485899 Anti-bacterial methods and materials
11/26/2002	US6485761 Incorporating into the dough one or more lactonohydrolases, to improve properties such as: strength, stability, stickiness, or machinability of the dough; volume, crumb structure, softness, flavor, and antistaling of the baked product
11/26/2002	US6485729 An anti-influenza vaccine, wherein the improvement comprises having as an additive a substantially pure, influenza neuraminidase and influenza hemagglutinin protein
11/26/2002	US6485724 Immortalized human keratinocyte cell line
11/26/2002	US6485722 Method for selective engraftment of drug-resistant hematopoietic stem cells
11/26/2002	US6485720 Transgene expression systems
11/26/2002	US6485719 Methods for inhibiting angiogenesis with leukocyte adhesion inhibitor-1 (LAI-1) polypeptides
11/26/2002	US6485690 Multiple fluid sample processor and system
11/26/2002	CA2244937C Identification of a dna region potentially useful for the detection of mycobacterium kansasii
11/26/2002	CA2228635C Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
11/26/2002	CA2210247C Modification of xylanase to improve thermophilicity, alkophilicity and thermostability
11/26/2002	CA2206451C Method for suppressing nonspecific hybridization in primer extension method
11/26/2002	CA2111573C Cadherin materials and methods
11/26/2002	CA2107672C Peptides and mixtures thereof for detecting antibodies to hepatitis c virus (hcv)
11/26/2002	CA2105984C Cloning and expression of renilla luciferase
11/26/2002	CA2098838C Liver enriched transcription factor
11/26/2002	CA2086643C Oxepane isomers of rapamycin useful as immunosuppressive agents
11/26/2002	CA2083377C Compositions and methods for modulating rna activity through modification of the 5' cap structure of rna
11/26/2002	CA2050533C Phage defense rotation strategy
11/26/2002	CA2027075C Mutein of hst-1 and production therof
11/26/2002	CA2026703C Genetic manipulations with recombinant dna comprising sequences derived from rna virus
11/26/2002	CA1341403C Recombinant a vipox virus
11/25/2002	CA2387332A1 Genetic polymorphisms in the human neurokinin 1 receptor gene and their uses in diagnosis and treatment of diseases
11/25/2002	CA2387277A1 Information processing system using nucleotide sequence-related information
11/22/2002	CA2383004A1 Non-anaphylactogenic ige vaccines
11/21/2002	WO2002093519A2 Human high-affinity antibody fragments for essential proteins of the hepatitis-c virus
11/21/2002	WO2002093177A2 Assays for identifying modulators of rhomboid polypeptides
11/21/2002	WO2002093176A2 Methods for identifying compounds for treatment of ibd
11/21/2002	WO2002092857A1 Chemically assembled nano-scale circuit elements
11/21/2002	WO2002092856A1 A method of selecting dna constructs for herbicide tolerance in plants
11/21/2002	WO2002092855A1 Antisense modulation of helicase-moi expression
11/21/2002	WO2002092854A2 Genes expressed in breast cancer as prognostic and therapeutic targets
11/21/2002	WO2002092852A2 Method for induction of genome instability
11/21/2002	WO2002092849A2 Methods
11/21/2002	WO2002092844A1 Thermostable proteinases from thermophilic bacteria
11/21/2002	WO2002092842A2 Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer
11/21/2002	WO2002092841A2 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
11/21/2002	WO2002092840A2 Agents that regulate apoptosis
11/21/2002	WO2002092835A2 Isolated human g protein-coupled receptor
11/21/2002	WO2002092832A2 Human and non-human primate homologues of nkd protein, nucleic acid sequences encoding, and uses thereof
11/21/2002	WO2002092831A2 Method for identifying ligands for g protein coupled receptors
11/21/2002	WO2002092829A1 Process for producing peptide
11/21/2002	WO2002092827A2 Corona-virus-like particles comprising functionally deleted genomes
11/21/2002	WO2002092826A2 Composition and method for treating cancer using herpes virus
11/21/2002	WO2002092825A2 Retroviral vectors for gene therapy
11/21/2002	WO2002092824A1 Method for producing transgenic monocotyledonous plants
11/21/2002	WO2002092823A1 Novel sequences and their use
11/21/2002	WO2002092822A2 Leaf specific gene promoter of coffee
11/21/2002	WO2002092821A1 Novel maxizyme
11/21/2002	WO2002092820A1 Lentil plants having increased resistance to imidazolinone herbicides
11/21/2002	WO2002092819A1 A variable region of the monoclonal antibody against the hbv s-surface antigen and a gene encoding the same
11/21/2002	WO2002092818A2 Streptococcus agalactiae genome sequence, use for developing vaccines, diagnostic tools, and for identifying therapeutic targets
11/21/2002	WO2002092817A1 Functions for d52 and ra006 nucleic acids and polypeptides
11/21/2002	WO2002092816A1 Replication vector showing cell-specific expression
11/21/2002	WO2002092815A2 Method of preparing polynucleotide fragments for use in shuffling, and shuffling of same
11/21/2002	WO2002092814A2 Screening method for attenuating or virulence defective microbial cells
11/21/2002	WO2002092812A1 ARTIFICIAL HUMAN CHROMOSOME CONTAINING HUMAN ANTIBODY μ LIGHT CHAIN GENE
11/21/2002	WO2002092809A1 Novel hexenuronidase, gene coding for the same, and use of these
11/21/2002	WO2002092808A1 Random gene unidirectional antisense library
11/21/2002	WO2002092807A1 Unigene unidirectional antisense library

1 ... 2654 2655 2656 2657 2658 2659 2660 2661 2662 2663 2664 2665 2666 2667 2668 2669 2670 2671 2672 2673 2674 ... 4023